ZengKui Guo
Mayo Clinic
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by ZengKui Guo.
Journal of Lipid Research | 2006
ZengKui Guo; Lianzhen Zhou; Michael D. Jensen
Hyperinsulinemia is common in obesity, but whether it plays a role in intramyocellular triglyceride (imcTG) buildup is unknown. In this study, hyperinsulinemic-euglycemic clamp experiments were performed in overnight-fasted lean and high-fat-fed obese rats, awake, to determine the effect of insulin on imcTG synthesis (incorporation of [14C]glycerol, [14C]glucose, and [3H]oleate). Insulin infusion at 25 (low insulin) and 100 (high insulin) pmol/kg/min increased plasma insulin by 5- and 16-fold, respectively, whereas plasma and intramyocellular glycerol, FFAs, triglycerides, and glucose levels were maintained at their basal levels by co-infusion of exogenous glycerol, FFAs, and triglycerides at fixed rates and glucose at varying rates. In obese rats, insulin suppressed incorporation of glycerol into the imcTG-glycerol moiety dose dependently (P < 0.01–P < 0.001) in gastrocnemius and tibialis anterior, but only the high insulin suppressed it in soleus (P < 0.05). The low insulin suppressed glucose incorporation into imcTG-glycerol in all three muscles (P = 0.01–P < 0.01). However, the low insulin did not affect (P > 0.05) and the high insulin suppressed (P < 0.05–P < 0.01) fatty acid incorporation into imcTG in all three muscles. Insulin also suppressed glycerol incorporation in lean rats (P < 0.01–P < 0.04). On the other hand, imcTG pool size was not affected by insulin (P > 0.05). These observations suggest that acute hyperinsulinemia inhibits imcTG synthesis and thus does not appear to promote imcTG accumulation via the synthetic pathway, at least in the short term.
Clinical Endocrinology | 2008
Morten Krag; Søren Nielsen; ZengKui Guo; Steen B. Pedersen; Ole Schmitz; Jens Sandahl Christiansen; Jens Otto Lunde Jørgensen
Context Peroxisome proliferator‐activated receptor gamma (PPAR‐γ) agonists such as thiazolidinediones (TZDs) improve insulin sensitivity in type 2 diabetes mellitus (T2DM) through effects on fat metabolism whereas GH stimulates lipolysis and induces insulin resistance.
Journal of Applied Physiology | 2000
ZengKui Guo; Bartolome Burguera; Michael D. Jensen
Journal of Clinical Investigation | 2003
Søren Nielsen; ZengKui Guo; Jeanine B. Albu; Samuel Klein; Peter C. O’Brien; Michael D. Jensen
American Journal of Physiology-endocrinology and Metabolism | 2007
Morten Krag; Lars Christian Gormsen; ZengKui Guo; Jens Sandahl Christiansen; Michael D. Jensen; Søren Nielsen; Jens Otto Lunde Jørgensen
Journal of Applied Physiology | 1998
ZengKui Guo; Michael D. Jensen
Journal of Lipid Research | 1997
ZengKui Guo; Søren Nielsen; Bartolome Burguera; Michael D. Jensen
Archive | 2015
Bartolome Burguera; Michael D. Jensen; Jill A. Kanaley; Samyah Shadid; Michael T. Sheehan; ZengKui Guo; Sørensen Larsen; Jens Otto; Lunde Jørgensen; Søren Steen Nielsen; Birgitte Nellemann; Britt Christensen; Kristian Vissing
The FASEB Journal | 2008
Jill A. Kanaley; Michael T. Sheehan; ZengKui Guo; Michael D. Jensen
9th European Congress of Endocrinology | 2007
Morten Krag; Søren Steen Nielsen; ZengKui Guo; Steen B. Pedersen; Ole Schmitz; Jens Sandahl Christiansen; Jens Ol Jørgensen